Full Professor(heuristic)

PARP inhibition in cancer therapy · Oncology

Compare more Oncology professors.

h-index38
i10-index45
Publications212
Citations24,053

Grants

No NSF/NIH grants on record.

Recent Public Signals

  1. New paper: Supplementary Table S8 from Characterization of TNG348: A Selective, Allosteric USP1 Inhibitor That Synergizes with PARP Inhibitors in Tumors with Homologous Recombination Deficiency2026-06-17

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

ORCID: 0000-0002-7026-2722

Professor Insights

Career Trajectory